Identity
- Trade Name
- Total T4 Thyroxine) FDA UDI
- Generic Name
- Total thyroxine (TT4) IVD, kit, chemiluminescent immunoassay FDA UDI
- Model / Reference
- 20739006322 FDA UDI
Identifiers
- Catalog Number
- 20739006322 FDA UDI
- Primary DI / UDI-DI
- 04015630916016 FDA UDI
- 510(k) Number
- K951595 FDA UDI
- FDA Product Code
- KLI FDA UDI
- GMDN Term
- Total thyroxine (TT4) IVD, kit, chemiluminescent immunoassay FDA UDI
Classification
- Device Class
- Class II FDA UDI
- Regulation Number
- 862.1700 FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
Yes
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
Yes
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
No
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
No
FDA UDI
Lot / Batch Number
Yes
FDA UDI
Serial Number
No
FDA UDI
Expiration Date
Yes
FDA UDI
Manufacturing Date
No
FDA UDI
Category: Total thyroxine (TT4) IVD, kit, chemiluminescent immunoassay
Total T4 Thyroxine) by Roche Diagnostics Corp. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as Total thyroxine (TT4) IVD, kit, chemiluminescent immunoassay.
- ARCHITECT — ABBOTT IRELAND · Class II
- Alinity — ABBOTT IRELAND · Class II
- Monobind AccuLite T4 CLIA Kit - 192 Wells — MONOBIND, INC. · Class II
- ARCHITECT — ABBOTT IRELAND · Class II
- T4 SBS AccuLite CLIA Test System - 192 Wells — MONOBIND, INC. · Class II
- Alinity — ABBOTT IRELAND · Class II
- ARCHITECT — ABBOTT IRELAND · Class II
- IMMULITE® 2000 Systems TT4 Total T4 — SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS LTD · Class II
Cleared under the same submission
K951595 also covers:
- Abuscreen OnLine Barbiturates — Roche Diagnostics Corp.
- Aspartate Aminotransferase acc to IFCC with pyridoxal phosphate activation — Roche Diagnostics Corp.
- Aspartate Aminotransferase acc to IFCC with pyridoxal phosphate activation — Roche Diagnostics Corp.
- Aspartate Aminotransferase acc to IFCC without pyridoxal phosphate activation — Roche Diagnostics Corp.
- Aspartate Aminotransferase acc to IFCC without pyridoxal phosphate activation — Roche Diagnostics Corp.
- Benzodiazepines — Roche Diagnostics Corp.
- Cannabinoids II — Roche Diagnostics Corp.
- Carbamazepine — Roche Diagnostics Corp.
- Creatine KinaseMB — Roche Diagnostics Corp.
- Creatine KinaseMB — Roche Diagnostics Corp.
- Creatinine Jaff Gen2 — Roche Diagnostics Corp.
- Creatinine Jaffe Gen.2 — Roche Diagnostics Corp.
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class II | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Roche Diagnostics Corp.
Sources (1)
- FDA UDI 6e2a933c-62c4-4d6f-8792-18727e6d45af 35 fields · synced May 30, 2026